Larson Financial Group LLC Gilead Sciences, Inc. Transaction History

Larson Financial Group LLC

$1.75 Billion
Q3 2024

A detailed history of Larson Financial Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 7,835 shares of GILD stock, worth $720,898. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,835

Previous 4,371 79.25%

Holding current value

$720,898

Previous $299,000 119.4%

% of portfolio

0.04%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $230,667 - $290,941	3,464 Added 79.25%	7,835 $656,000
Q2 2024 Aug 02, 2024	BUY	$63.15 - $72.88 $181,745 - $209,748	2,878 Added 192.77%	4,371 $299,000
Q1 2024 May 03, 2024	BUY	$71.58 - $87.29 $19,756 - $24,092	276 Added 22.68%	1,493 $109,000
Q4 2023 Feb 01, 2024	BUY	$73.27 - $83.09 $1,318 - $1,495	18 Added 1.5%	1,217 $98,000
Q3 2023 Nov 03, 2023	BUY	$73.94 - $80.67 $11,534 - $12,584	156 Added 14.96%	1,199 $89,000
Q2 2023 Aug 03, 2023	BUY	$76.01 - $86.7 $6,384 - $7,282	84 Added 8.76%	1,043 $80,000
Q1 2023 May 04, 2023	SELL	$77.31 - $88.08 $12,601 - $14,357	-163 Reduced 14.53%	959 $79,000
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $14,520 - $20,846	233 Added 26.21%	1,122 $96,000
Q3 2022 Nov 03, 2022	BUY	$59.54 - $68.01 $3,572 - $4,080	60 Added 7.24%	889 $55,000
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $865 - $975	15 Added 1.84%	829 $51,000
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $521 - $653	9 Added 1.12%	814 $48,000
Q4 2021 Feb 03, 2022	SELL	$64.88 - $73.64 $5,125 - $5,817	-79 Reduced 8.94%	805 $58,000
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $10,965 - $11,830	-162 Reduced 15.49%	884 $62,000
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $10,218 - $11,165	161 Added 18.19%	1,046 $72,000
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $10,680 - $12,185	178 Added 25.18%	885 $57,000
Q4 2020 Jan 14, 2021	BUY	$56.65 - $64.55 $509 - $580	9 Added 1.29%	707 $41,000
Q3 2020 Oct 08, 2020	BUY	$62.1 - $78.08 $124 - $156	2 Added 0.29%	698 $44,000
Q2 2020 Jul 10, 2020	SELL	$72.34 - $84.0 $6,293 - $7,308	-87 Reduced 11.11%	696 $54,000
Q1 2020 Apr 09, 2020	BUY	$62.63 - $80.22 $9,269 - $11,872	148 Added 23.31%	783 $59,000
Q4 2019 Jan 10, 2020	SELL	$61.62 - $67.78 $11,769 - $12,945	-191 Reduced 23.12%	635 $41,000
Q3 2019 Oct 11, 2019	BUY	$62.51 - $69.0 $12,126 - $13,386	194 Added 30.7%	826 $52,000
Q2 2019 Jul 16, 2019	BUY	$61.87 - $69.38 $804 - $901	13 Added 2.1%	632 $43,000
Q1 2019 Apr 05, 2019	BUY	$62.53 - $70.05 $375 - $420	6 Added 0.98%	619 $40,000
Q4 2018 Feb 07, 2019	BUY	$60.54 - $79.0 $37,111 - $48,427	613 New	613 $38,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.

Account

Larson Financial Group LLC Gilead Sciences, Inc. Transaction History